Treating bleeding oesophageal varices with vasoactive agents: good value for money?

J. N. Plevris*, P. C. Hayes

*Corresponding author for this work

Research output: Contribution to journalLiterature reviewpeer-review

Abstract / Description of output

This article provides an editorial commentary to accompany the publication of an article on the economic evaluation of vasoactive agents used in the United Kingdom for acute bleeding oesophageal varices in patients with cirrhosis by Wechowski et at From a clinical standpoint, the successful management of bleeding oesophageal varices should be based on definitive treatments such as therapeutic endoscopy or transjugular intrahepatic portosystemic stent shunt (TIPSS). Vasoactive agents such as terlipressin can be useful and potentially cost-effective additional therapy, however, particularly in patients where endoscopic treatment is likely to be delayed or is contraindicated.

Original languageEnglish
Pages (from-to)1745-1747
Number of pages3
JournalCurrent medical research and opinion
Issue number7
Publication statusPublished - Jul 2007

Keywords / Materials (for Non-textual outputs)

  • bleeding oesophageal varices
  • cirrhosis
  • endoscopy, therapeutic
  • liver disease, chronic
  • vasoactive agents


Dive into the research topics of 'Treating bleeding oesophageal varices with vasoactive agents: good value for money?'. Together they form a unique fingerprint.

Cite this